SYK - Earnings announcements

Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billionOrganic net sales increased 2.4%Reported operating income margin of 15.5%Adjusted operating income margin(1) contracted 180 bps to 21.1%Reported EPS increased 14.2% to $1.93 Adjusted EPS(1) decreased 8.5% to $2.60  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        5.0        %         1.4        %         3.6        %         2.7        %         0.9        %Orthopaedics        

Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        14.4        %         0.5        %         13.9        %         5.5        %         8.4        %Orthopaedics        3

Portage, Michigan, July 31, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2025: Second Quarter Results Reported net sales increased 11.1% to $6.0 billionOrganic net sales increased 10.2%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 110 bps to 25.7%Reported EPS increased 7.0% to $2.29Adjusted EPS(1) increased 11.4% to $3.13  Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.3        %         0.6        %         16.7        %         5.7        %         11.0        %Orthopaedics   

Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billionOrganic net sales increased 10.1%Reported operating income margin of 14.3%Adjusted operating income margin(1) increased 100 bps to 22.9%Reported EPS decreased 17.6% to $1.69Adjusted EPS(1) increased 13.6% to $2.84  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        13.4        %         (0.8)        %         14.2        %         3.5        %         10.7        %Orthopaedics    

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billionOrganic net sales increased 10.2%Reported operating income margin of 9.0%Adjusted operating income margin(1) increased 200 bps to 29.2%Reported EPS decreased 52.7% to $1.41Adjusted EPS(1) increased 15.9% to $4.01  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        10.6        %         (0.5)        %         11.1        %         1.0        %         10.1        

Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) -- reported operating results for the third quarter of 2024: Third Quarter Results Reported net sales increased 11.9% to $5.5 billionOrganic net sales increased 11.5%Reported operating income margin of 19.7%Adjusted operating income margin(1) increased 130 bps to 24.7%Reported EPS increased 20.0% to $2.16Adjusted EPS(1) increased 16.7% to $2.87  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        12.8        %         (0.1)        %         12.9        %         0.2        %         12.7        %Orthopaedics and Spine        10.7

Portage, Michigan, July 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2024: Second Quarter Results Reported net sales increased 8.5% to $5.4 billionOrganic net sales increased 9.0%Reported operating income margin of 19.4%Adjusted operating income margin(1) increased 30 bps to 24.6%Reported EPS increased 10.9% to $2.14Adjusted EPS(1) increased 10.6% to $2.81  Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        9.0        %         (0.8)        %         9.8        %         0.1        %         9.7       

Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 80 bps to 21.9%Reported EPS increased 33.1% to $2.05Adjusted EPS(1) increased 16.8% to $2.50  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        11.5        %         (0.5)        %         12.0        %         0.4        %         11.6

Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin of 21.6%Adjusted operating income margin(1) increased 60 bps to 27.2%Reported EPS increased 102.7% to $2.98Adjusted EPS(1) increased 15.3% to $3.46  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        12.3        %         0.3        %         12.0        %         0.2        %  

Kalamazoo, Michigan, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 billionOrganic net sales increased 9.2%Reported operating income margin of 19.0%Adjusted operating income margin(1) increased 110 bps to 23.4%Reported EPS decreased 15.9% to $1.80 Adjusted EPS(1) increased 16.0% to $2.46  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        10.5        %         0.2        %         10.3        %         0.2        %         10.1        %Orthop

Kalamazoo, Michigan, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billionOrganic net sales increased 11.9%Reported operating income margin of 19.3%Adjusted operating income margin(1) increased 60 bps to 24.3%Reported EPS increased 12.2% to $1.93Adjusted EPS(1) increased 12.9% to $2.54  Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        12.2        %         (0.7)        %         12.9        %         —        %         12.9       

Kalamazoo, Michigan, May 01, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results Reported net sales increased 11.8% to $4.8 billionOrganic net sales increased 13.6%Reported operating income margin of 15.4%Adjusted operating income margin(1) contracted 70 bps to 21.1%Reported EPS increased 83.3% to $1.54Adjusted EPS(1) increased 8.6% to $2.14  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        11.0        %         (2.1)        %         13.1        %         0.7        %         12.4        %Orthopaedi

Kalamazoo, Michigan , Jan. 31, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billionOrganic net sales increased 13.2%Reported operating income margin of 15.6%Adjusted operating income margin(1) contracted 70 bps to 26.6%Reported EPS decreased 15.0% to $1.47Adjusted EPS(1) increased 10.7% to $3.00  Fourth Quarter Net Sales Growth Overview             Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        15.6    %         (3.7)    %         19.3    %         2.4    %         16

Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q4 and Full Year 2022 Earnings Call.  After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure

Kalamazoo, Michigan, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results Reported net sales increased 7.7% to $4.5 billionOrganic net sales increased 9.9%Reported operating income margin of 18.0%Adjusted operating income margin(1) contracted 310 bps to 22.3%Reported EPS increased 87.7% to $2.14Adjusted EPS(1) decreased 3.6% to $2.12  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        10.2%         (3.3)   %         13.5%         2.7 %         10.8%Orthop

Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q3 2022 Earnings call. After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you ar

Kalamazoo, Michigan, July 26, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2022: Second Quarter Results Reported net sales increased 4.6% to $4.5 billionOrganic net sales increased 6.1%Reported operating income margin of 17.2%Adjusted operating income margin(1) contracted 220 bps to 23.7%Reported EPS increased 11.0% to $1.72 Adjusted EPS(1) of $2.25 in line with 2021  Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        8.0        %         (2.6)         %    

Kalamazoo, Michigan, June 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. Final operating results for the quarter ended June 30, 2022 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q2 2022 Earnings call. After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To e

Kalamazoo, Michigan, April 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2022: First Quarter Results Reported net sales increased 8.1% to $4.3 billionOrganic net sales increased 9.2%Reported operating income margin of 10.5%Adjusted operating income margin(1) contracted 170 bps to 21.8%Reported EPS increased 6.3% to $0.84 Adjusted EPS(1) increased 2.1% to $1.97  First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        10.6%         (1.5)%         12.1%         1.3%         10.8%Orthopaedics and Spine        5.1      

Kalamazoo, Michigan, March 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operational update.Final operating results for the quarter ended March 31, 2022 will be released at 4:05 p.m. that day.  To register for this conference call, please use the following link: Stryker's Q1 2022 earnings call. After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ens

Kalamazoo, Michigan, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2021: Fourth Quarter Results Reported net sales increased 10.3% from 2020 and 13.8% from 2019 to $4.7 billionOrganic net sales increased 9.0% from 2020 and 6.2% from 2019Reported operating income margin of 17.4%Adjusted operating income margin(1) contracted 190 bps to 27.3%Reported EPS increased 16.1% to $1.73 Adjusted EPS(1) decreased 3.6% to $2.71 In addition to sales growth analysis versus 2020, we are includi

Kalamazoo, Michigan, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. (NYSE:VCRA) for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion (including convertible notes). Vocera, which was founded in 2000, has emerged as a leading platform in the digital care coordination and communication category. The importance of this growing segment has continued to expand throughout the pandemic as it aims to reduce cognitive overload for caregivers and enables them to deliver

Kalamazoo, Michigan, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an operational update. Final operating results for the quarter ended December 31, 2021 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q4 2021 earnings call. After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call

Kalamazoo, MI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2021: Third Quarter Results Reported net sales increased 11.3% from 2020 and 16.0% from 2019 to $4.2 billionOrganic net sales increased 4.5% from 2020 and 8.4% from 2019Reported operating income margin of 13.8%Adjusted operating income margin(1) contracted 260 bps to 25.4%Reported EPS decreased 30.1% to $1.14 Adjusted EPS(1) increased 2.8% to $2.20 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pa

Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an operational update. Final operating results for the quarter ended September 30, 2021 will be released at 4:05 p.m. that day. To participate in the conference call dial (833) 979-2711 (domestic) or (236) 714-2206 (international) and enter passcode 7351349. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on the Investor Relations page of t

Kalamazoo, Michigan, July 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2021: Second Quarter Results Reported net sales increased 55.4% from 2020 and 17.6% from 2019 to $4.3 billionOrganic net sales increased 42.9% from 2020 and 9.3% from 2019Reported operating income margin of 17.0%Adjusted operating income margin(1) of 25.9%Reported EPS of $1.55 Adjusted EPS(1) of $2.25 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020.